In fact, the diagnosis of PLNTY relies on the following essential criteria: “diffuse growth pattern and oligodendroglioma-like component and few (if any) mitotic figures and regional CD34 expression and IDH-wild type status and BRAF V600E mutation or FGFR2 or 3 fusions”. This evidence concerns the gene BRAF and oligodendroglioma.